Elevated serum C-reactive protein levels as a predictive indicator for subsequent renal impairment in patients with acute heart failure

Tohoku Journal of Experimental Medicine

Volumn 213, Issue 4, 2007, Pages 361-368

  Fukumoto, Yoshihiro ^a,b,d   Kishi, Takuya ^a,b   Tsutsui, Hiroyuki ^a,c   Yamada, Akira ^b   Okamatsu, Shuichi ^b   Takeshita, Akira ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b ASO IIZUKA HOSPITAL   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute heart failure; C reactive protein; Infection; Inflammation; Renal dysfunction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CATECHOLAMINE; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NITRATE; PHOSPHODIESTERASE III INHIBITOR; SPIRONOLACTONE; TRIACYLGLYCEROL; UREA;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRAIN INFARCTION; CHRONIC KIDNEY FAILURE; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; UREA NITROGEN BLOOD LEVEL; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

AGED; C-REACTIVE PROTEIN; FEMALE; HEART FAILURE; HUMANS; KIDNEY DISEASES; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS;

EID: 38049100882     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.213.361     Document Type: Article

References (27)

1. Alonso-Martinez, J.L., Llorente-Diez, B., Echegaray-Agara, M., Olaz-Preciado, F., Urbieta-Echezarreta, M. & Gonzalez-Arencibia, C. (2002) C-reactive protein as a predictor of improvement and readmission in heart failure. Eur. J. Heart Fail., 4, 331-336.
2. Andreassen, A.K., Nordoy, I., Simonsen, S., Ueland, T., Muller, F., Froland, S.S., Gullestad, L. & Aukrust, P. (1998) Levels of circulating adhesion molecules in congestive heart failure and after heart transplantation. Am. J. Cardiol., 81, 604-608.
3. Bongartz, L.G., Cramer, M.J., Doevendans, P.A., Joles, J.A. & Braam, B. (2005) The severe cardiorenal syndrome: "Guyton revisited". Eur. Heart J., 26, 11-17.
4. Chin, B.S., Conway, D.S., Chung, N.A., Blann, A.D., Gibbs, C.R. & Lip, G.Y. (2003) Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood Coagul Fibrinolysis, 14, 515-521.
5. Deliargyris, E.N., Raymond, R.J., Theoharides, T.C., Boucher, W.S., Tate, D.A. & Dehmer, G.J. (2000) Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am. J. Cardiol., 86, 913-918.
6. Duffield, J.S., Erwig, L.P., Wei, X., Liew, F.Y., Rees, A.J. & Savill, J.S. (2000) Activated macrophages direct apoptosis and suppress mitosis of mesangial celIs. J. Immunol., 164, 2110-2119.
7. Fonarow, G.C., Adams, K.F., Jr., Abraham, W.T., Yancy, C.W. & Boscardin, W.J. (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA, 293, 572-580.
8. Fonarow, G.C. & Heywood, J.T. (2006) The confounding issue of comorbid renal insufficiency. Am. J. Med., 119, S17-S25.
9. Fukumoto, Y., Shimokawa, H., Ito, A., Kadokami, T., Yonemitsu, Y., Aikawa, M., Owada, M.K., Egashira, K., Sueishi, K., Nagai, R., Yazaki, Y. & Takeshita, A. (1997) Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. J. Cardiovasc. Pharmacol., 29, 222-231.
10. Fukumoto, Y., Tsutsui, H., Tsuchihashi, M., Masumoto, A. & Takeshita, A. (2003) The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J. Am. Coll. Cardiol., 42, 211-216.
11. Gheorghiade, M., De Luca, L., Fonarow, G.C., Filippatos, G., Metra, M. & Francis, G.S. (2005a) Pathophysiologic targets in the early phase of acute heart failure syndromes. Am. J. Cardiol., 96, 11G-17G.
12. Gheorghiade, M., Zannad, F., Sopko, G., Klein, L., Pina, I.L., Konstam, M.A., Massie, B.M., Roland, E., Targum, S., Collins, S.P., Filippatos, G. & Tavazzi, L. (2005b) Acute heart failure syndromes: current state and framework for future research. Circulation, 112, 3958-3968.
13. Gheorghiade, M., Filippatos, G., De Luca, L. & Burnett, J. (2006) Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am. J. Med., 119, S3-S10.
14. Gonzalez, M.A. & Selwyn, A.P. (2003) Endothehal function, inflammation, and prognosis in cardiovascular disease. Am. J. Med., 115, Suppl. 8A, 99S-106S.
15. Horwich, T.B., Hamilton, M.A., Maclellan, W.R. & Fonarow, G.C. (2002) Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J. Card Fail., 8, 216-224.
16. Lassus, J., Harjola, V.P., Sund, R., Siirila-Waris, K., Melin, J., Peuhkurinen, K., Pulkki, K. & Nieminen, M.S. (2007) Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur. Heart J., 28, 1841-1847.
17. Panzer, U., Steinmetz, O.M., Stahl, R.A. & Wolf, G. (2006) Kidney diseases and chemokines. Curr. Drug Targets., 7, 65-80.
18. Paul, A., Ko, K.W., Li, L., Yechoor, V., McCrory, M.A., Szalai, A.J. & Chan, L. (2004) C-reactiveprotein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 109, 647-655.
19. Peschel, T., Schonatier, M., Thiele, H., Anker, S.D., Schuler, G. & Niebauer, J. (2003) Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur. J. Heart Fail., 5, 609-614.
20. Ridker, P.M. & Morrow, D.A. (2003) C-reactive protein, inflammation, and coronary risk. Cardiol. Clin., 21, 315-325.
21. Sato, Y., Takatsu, Y., Kataoka, K., Yamada, T., Taniguchi, R., Sasayama, S. & Matsumori, A. (1999) Serial circulating concentrations of C-reactive protein, interleukin (IL)-4 and IL-6 in patients with acute left heart decompensation. Clin. Cardiol., 22, 811-813.
22. Schrier, R.W. & Abraham, W.T. (1999) Hormones and hemodynamics in heart failure. N. Engl. J. Med., 341, 577-585.
23. Tsuchihashi, M., Tsutsui, H., Kodama, K., Kasagi, F. & Takeshita, A. (2000) Clinical characteristics and prognosis of hospitalized patients with congestive heart failure - a study in Fukuoka, Japan. Jpn. Circ. J., 64, 953-959.
24. Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P. & Jialal, I. (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 106, 1439-1441.
25. Verma, S., Wang, C.H., Li, S.H., Dumont, A.S., Fedak, P.W., Badiwala, M.V., Dbillon, B., Weisel, R.D., Li, R.K., Mickle, D.A. & Stewart, D.J. (2002) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulaqon, 106, 913-919.
26. Williams, T.N., Zhang, C.X., Game, B.A., He, L. & Huang, Y. (2004) C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc[gamma]RII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler Thromb Vasc. Biol., 24, 61-06.
27. Zager, R.A., Johnson, A.C., Hanson, S.Y. & Lund, S. (2006) Acute nephrotoxic and obstructive injury primes the kidney to endotoxin-driven cytokine/chemokine production. Kidney Int., 69, 1181-1188.